Insulin-dependent Diabetes Mellitus
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D
DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With MDI Therapy
Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes
Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment
Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics
Interferon-Alpha for Diabetes Mellitus Type 1
African-American Diabetes Intervention Project